Mirae Asset Global Investments’s Aquestive Therapeutics AQST Stock Holding History

Mirae Asset Global Investments’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.3K	Sell	5,611 -753	-12%	-$3.17K	﹤0.01%	1468
2026 Q1	$26.4K	Buy	6,364 +435	+7%	+$1.76K	﹤0.01%	1396
2025 Q4	$38.3K	Buy	5,929 +1,252	+27%	+$7.8K	﹤0.01%	1448
2025 Q3	$26.1K	Buy	4,677 +840	+22%	+$3.63K	﹤0.01%	1454
2025 Q2	$12.7K	Buy	3,837 +653	+21%	+$1.87K	﹤0.01%	1455
2025 Q1	$9.62K	Buy	3,184 +146	+5%	+$442	﹤0.01%	1472
2024 Q4	$10.7K	Buy	+3,038	New	+$14K	﹤0.01%	1510

Other funds holding AQST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

EAM

Everstar Asset Management Mooresville, North Carolina $207M AUM 18.14% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mirae Asset Global Investments's AQST Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Aquestive Therapeutics (AQST) stake by 12% in Q2 2026, selling an estimated $3.17K and leaving 5,611 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

Mirae Asset Global Investments first reported a position in AQST in Q4 2024 and has held it in 7 quarters since. The position peaked at $38.3K in Q4 2025. 69 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Mirae Asset Global Investments held 5,611 shares of Aquestive Therapeutics worth $23.3K as of Q2 2026.
Mirae Asset Global Investments sold 753 Aquestive Therapeutics shares in Q2 2026, an estimated $3.17K.
Aquestive Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1468 holding.
Mirae Asset Global Investments first reported a position in Aquestive Therapeutics in Q4 2024 and has held it in 7 quarters since.
Mirae Asset Global Investments's Aquestive Therapeutics position peaked at $38.3K in Q4 2025.
69 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.